Curative Biotechnology Inc (NYSE MKT:CUBT) — Market Cap & Net Worth
Market Cap & Net Worth: Curative Biotechnology Inc (CUBT)
Curative Biotechnology Inc (NYSE MKT:CUBT) has a market capitalization of $7.66 Million ($7.66 Million) as of July 22, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #27703 globally and #5649 in its home market, demonstrating a 49.63% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curative Biotechnology Inc's stock price $1.00 by its total outstanding shares 7658608 (7.66 Million). Review CUBT cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
Curative Biotechnology Inc Market Cap History: 2015 to 2026
Curative Biotechnology Inc's market capitalization history from 2015 to 2026. Data shows growth from $11.49K to $7.66 Million (84.76% CAGR).
Curative Biotechnology Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curative Biotechnology Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.14x
Curative Biotechnology Inc's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.53K | $11.09K | -$17.40K | 0.14x | N/A |
Competitor Companies of CUBT by Market Capitalization
Companies near Curative Biotechnology Inc in the global market cap rankings as of July 22, 2026.
Key companies related to Curative Biotechnology Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #542 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $482.00 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $675.19 |
| #542 | Argen-X | BR:ARGX | $49.55 Billion | €760.20 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €243.90 |
Curative Biotechnology Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Curative Biotechnology Inc's market cap moved from $11.49K to $ 7.66 Million, with a yearly change of 84.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.66 Million | +18418.52% |
| 2025 | $41.36K | -44.33% |
| 2024 | $74.29K | -54.46% |
| 2023 | $163.13K | +6.50% |
| 2022 | $153.17K | -62.96% |
| 2021 | $413.56K | +78.81% |
| 2020 | $231.29K | +1272.73% |
| 2019 | $16.85K | +2100.00% |
| 2018 | $765.86 | 0.00% |
| 2017 | $765.86 | -50.00% |
| 2016 | $1.53K | -86.67% |
| 2015 | $11.49K | -- |
End of Day Market Cap According to Different Sources
On Jul 22nd, 2026 the market cap of Curative Biotechnology Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.66 Million USD |
| MoneyControl | $7.66 Million USD |
| MarketWatch | $7.66 Million USD |
| marketcap.company | $7.66 Million USD |
| Reuters | $7.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Curative Biotechnology Inc
Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody carrying… Read more